You're viewing a free preview.You're viewing a free preview — a sample of each dataset.
Companies
The longevity science company universe by segment, stage, geography and capital raised.
724 companies tracked
| Company | Focus area | Funding |
|---|---|---|
| iBio | Cardiovascular & Metabolic Disease | — |
| Recover Society | Longevity Clinics | — |
| The Longevity Practice | Longevity Clinics | — |
| MoleQlar | Diagnostics & Biomarkers | — |
| Jupiter Neurosciences | Neurodegeneration & CNS | $11M+ |
| Niagen Bioscience | Supplements & Nutraceuticals | — |
| INBRAIN Neuroelectronics | Neurodegeneration & CNS | $68M |
| Sensible Biotechnologies | Cell & Gene Therapy | $47M+ |
| Sava | Wearables & Digital Health | $68M |
| Restore Hyper Wellness | Longevity Clinics | $140M+ |
Showing 10 of 724 companies
7-day free trial · already have an account?
Peek at other modules
News Feed
Daily longevity science headlines — aging research, deals, trials, and policy — with AI summaries.
Funding Tracker
Every disclosed longevity science round — size, stage and the investors behind it.
Clinical Trials
Longevity science and aging research trials by phase, sponsor, status and indication.
People & Movers
Who is joining, leaving and founding across longevity science and aging research.
Research
Peer-reviewed aging research distilled into investor-relevant takeaways.
Regulatory
FDA, EMA and policy developments that move aging research and the longevity market.